| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |